Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Psoter, Kevin J ^a   De Roos, Anneclaire J ^b   Wakefield, Jon ^c   Mayer, Jonathan D ^c   Rosenfeld, Margaret ^d,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Achromobacter xylosoxidans, Haemophilus influenzae; Cystic fibrosis; MRSA; Seasonality; Stenotrophomonas maltophilia

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ARTICLE; AUTUMN; BACTERIUM; CHILD; CYSTIC FIBROSIS; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; RESPIRATORY BACTERIA; RETROSPECTIVE STUDY; SEASONAL VARIATION; SPRING; STENOTROPHOMONAS MALTOPHILIA; SUMMER; UNITED STATES; WINTER; ACHROMOBACTER DENITRIFICANS; CLIMATE; COMPLICATION; HAEMOPHILUS INFECTIONS; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; PATHOGENICITY; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SEASON; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ACHROMOBACTER DENITRIFICANS; CHILD, PRESCHOOL; CLIMATE; CYSTIC FIBROSIS; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SEASONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; UNITED STATES;

EID: 85020457846     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2511-9     Document Type: Article

References (35)

1. Cystic Fibrosis Foundation. Patient registry 2012 annual report. Bethesda: Cystic Fibrosis Foundation; 2013.
2. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23:299-323.
3. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas Aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34:91-100.
4. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, et al. Clinical outcome after early Pseudomonas Aeruginosa infection in cystic fibrosis. J Pediatr. 2001;138:699-704.
5. Hauser AR, Jain M, Bar-Meir M, McColley SA. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev. 2011;24:29-70.
6. Ciofu O, Hansen CR, Hoiby N. Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med. 2013;19:251-8.
7. Fisman DN. Seasonality of infectious diseases. Annu Rev Public Health. 2007;28:127-43.
8. Richet H. Seasonality in gram-negative and healthcare-associated infections. Clin Microbiol Infect. 2012;18:934-40.
9. Freeman J, Anderson D, Sexton DJ. Emerging evidence for seasonality of gram-negative bacterial infections. Infect Control Hosp Epidemiol. 2009;30:813-4.
10. Psoter KJ, De Roos AJ, Wakefield J, Mayer J, Rosenfeld M. Season is associated with Pseudomonas Aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect. 2013;19:E483-9.
11. Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, et al. The Cystic Fibrosis Foundation patient registry. Design and methods of a National Observational Disease Registry. Ann Am Thorac Soc. 2016;13:1173-9.
12. Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155:S73-93.
13. Saiman L, Siegel J, Cystic FF. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol. 2003;24:S6-52.
14. Peel MC, Finlayson BL, McMahon TA. Updated world map of the Koppen-Geiger climate classification. Hydrol Earth Syst Sci. 2007;11:1633-44.
15. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2013.
16. Naumova EN. Mystery of seasonality: getting the rhythm of nature. J Public Health Policy. 2006;27:2-12.
17. Dowell SF. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis. 2001;7:369-74.
18. Nelson RJ, Drazen DL. Melatonin mediates seasonal adjustments in immune function. Reprod Nutr Dev. 1999;39:383-98.
19. Kidd TJ, Ramsay KA, Vidmar S, Carlin JB, Bell SC, Wainwright CE, et al. Pseudomonas Aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. J Cyst Fibros. 2015;14:361-9.
20. Psoter KJ, De Roos AJ, Wakefield J, Mayer JD, Bryan M, Rosenfeld M. Association of meteorological and geographical factors and risk of initial Pseudomonas Aeruginosa acquisition in young children with cystic fibrosis. Epidemiol Infect. 2016;144:1075-83.
21. Collaco JM, McGready J, Green DM, Naughton KM, Watson CP, Shields T, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One. 2011;6:e27784.
22. Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol. 1999;26:189-95.
23. Ortiz JR, Neuzil KM, Victor JC, Wald A, Aitken ML, Goss CH. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest. 2010;137:852-60.
24. Somayaji R, Goss CH, Khan U, Neradilek M, Neuzil KM, Ortiz JR. Cystic fibrosis pulmonary exacerbations attributable to respiratory syncytial virus and influenza: a population-based study. Clin Infect Dis. 2017;In Press.
25. Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, et al. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007;42:513-8.
26. Sawicki GS, Rasouliyan L, Ren CL. The impact of MRSA on lung function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2009;179:734-5.
27. Champion EA, Miller MB, Popowitch EB, Hobbs MM, Saiman L, Muhlebach MS, et al. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis. Pediatr Pulmonol. 2014;49:230-7.
28. Mermel LA, Machan JT, Parenteau S. Seasonality of MRSA infections. PLoS One. 2011;6:e17925.
29. Klein EY, Sun L, Smith DL, Laxminarayan R. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. Am J Epidemiol. 2013;177:666-74.
30. Leekha S, Diekema DJ, Perencevich EN. Seasonality of staphylococcal infections. Clin Microbiol Infect. 2012;18:927-33.
31. Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas Aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol. 1992;12:158-61.
32. Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfalt R, Lindblad A, et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol. 2002;33:483-91.
33. Chmiel JF, Berger M, Konstan MW. The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol. 2002;23:5-27.
34. Doring G, Flume P, Heijerman H, Elborn JS, Consensus SG. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros. 2012;11:461-79.
35. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol. 1999;28:321-8.